Solomon Rosenblatt
Chemist, Inventor, Entrepeneur
Solomon Rosenblatt,
Born on July 17, 1929, in East New York, Solomon Rosenblatt developed a passion for problem-solving and chemistry early in life, building a small laboratory at home.
After studying the sciences at the City College of New York, Sol’s first professional role involved evaluating paint quality for the City of New York, where he invented a water-based enamel.
With his new wife Vicky, the Rosenblatts moved to California where Sol worked on Polaris nuclear submarines. While there, he developed an epoxy propellant.
Moving to New England in the mid-1960s, he worked as a life support chemist for the Apollo mission. His work included designing fuel cell separator membranes, and a self-sealing device to close potential meteorite holes.
Learning about the possibility of transfer of viruses in the cockpit, he proposed to NASA to investigate antimicrobials to protect the astronauts and the moon environment. His attention turned to iodine, which as an element native to the earth and the moon, and with its powerful, but uncontrollable antimicrobial capabilities, seemed an interesting area for research.
Though this was not pursued by NASA, this fueled a life-long passion for medicine. He found a way to apply the semi-permeable Apollo membranes to heart-lung machines.
In response to the need for lint-free surgical tools, he invented Merocel, a sponge that became a critical tool in microsurgery.
Founded in Mystic, Connecticut, the Merocel Corporation grew to employ over 100 people and was eventually acquired by Medtronic in the 1990s.
After retiring, Sol returned to his interest in the properties of iodine from his Apollo days.
He developed an iodine-based patch which was tested and definitively killed the Herpes virus, a virus more resistant than small pox.
Sol’s concern about drug resistance due to antibiotic overuse led him on a forty year exploration to develop a biocompatible antimicrobial bandage for chronic wounds.
This eventually led to the creation of the bandage, became known as IoPlex.
And after more years of research, his next two inventions: IoWipe and I-Sorbe are now fully developed, patent pending, and ready to take out into the world.
You can read more about how you might be involved in their commercialization here...
Patents Pertaining to IoPlex and Its Derivatives
IoPlex
Non-Provisional Patent granted 9/20/2022
01
IoWipe
Depending on use, IoWipe is covered by the IoPlex patent. We've also filed a Provisional Patent for non-prior art uses on 12/1/2024.
02
I-Sorbe
- Provisional Patent granted 02/21/2024
- Non-Provisional Patent filed 09/27/2024
03
Your Next Big Opportunity in Wound Care
and Infection Control
If you’re a broker or development firm ready to help shape the future of healthcare products, we want to work with you.
We're looking to partner with:
- Contract Research Organizations (CROs) with FDA Expertise
- Full-Service Product Development Firms in Healthcare
- Regulatory Consultants with FDA Specialization
- Industry Consultants
- Companies with a proven track record in taking an invention thru testing, FDA approval, marketing and manufacture
If this describes your company, we ready to:
- Meet with you to give detailed product information (with an NDA)
- Send you samples to test and examine
- Hand off our inventions to the right Team to take these
Let’s talk about developing these breakthrough, next-generation technologies based on IoPlex, the mature, FDA approved Medline-marketed wound-care bandages.
Contact us to inquire about how your company can bring our mission-critical antimicrobial products to the market and to express your interest or questions.
©Copyright. All rights reserved.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.